Drug General Information (ID: DDIEH3TVBU)
  Drug Name Levothyroxine Drug Info Labetalol Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antithyroid Agents Antihypertensive Agents
  Structure

 Mechanism of Levothyroxine-Labetalol Interaction (Severity Level: Minor)
     Increased metabolism (Unspecific) Click to Show/Hide Mechanism Graph
      Drug Name Levothyroxine Labetalol
      Mechanism Increase in hepatic metabolism of beta blocker by reversing decreased hepatic blood flow associated with hypothyroidism
Increase in hepatic metabolism of beta-blocker by reversing decreased hepatic blood flow associated with hypothyroidism 
Beta blocker
      Key Mechanism Factor 1
Factor Name Pharmacokinetics
Factor Description Alters the metabolism of the drug, leading to changes in the plasma concentration of the drug and affecting the pharmacological effects.
      Mechanism Description
  • Increased metabolism of Labetalol caused by Levothyroxine 

References
1 Wohlt PD, Zheng L, Gunderson S, Balzar SA, Johnson BD, Fish JT "Recommendations for the use of medications with continuous enteral nutrition." Am J Health Syst Pharm 66 (2009): 1438-67. [PMID: 19667002]
2 Aro A, Antila M, Korhonen T, Sundquist H "Pharmacokinetics of propranolol and sotalol in hyperthyroidism." Eur J Clin Pharmacol 21 (1982): 373-7
3 Wells PG, Feely J, Wilkinson GR, Wood AJ "Effect of thyrotoxicosis on liver blood flow and propranolol disposition after long-term dosing." Clin Pharmacol Ther 33 (1983): 603-8